House Foods Group (2810) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
4 Aug, 2026Executive summary
Operating profit rose 17.1% year-over-year to 4,001 million yen, driven by strong performance in core food segments and extraordinary gains.
Net sales declined 0.7% year-over-year to 75,139 million yen, mainly due to the sale of the prepared foods business; on a like-for-like basis, all segments saw sales growth.
Profit attributable to owners of parent surged 185.3% year-over-year to 5,136 million yen, reflecting a gain on sale of investment securities.
Comprehensive income increased 250.9% year-over-year to 3,825 million yen.
Financial highlights
Gross profit increased to 28,454 million yen from 27,490 million yen year-over-year.
Operating profit margin improved to 5.3% from 4.5% year-over-year.
EBITDA margin was 9.6% for the quarter.
EPS (basic) rose to 56.98 yen from 19.20 yen year-over-year.
Equity ratio stood at 67.9%, up from 67.0% at the previous fiscal year-end.
Outlook and guidance
Full-year net sales forecast maintained at 322,500 million yen, up 1.7% year-over-year.
Operating profit forecast revised down to 17,500 million yen (down 4.1% year-over-year) due to rising costs.
Profit attributable to owners of parent projected at 17,000 million yen, up 131% year-over-year.
Dividend forecast unchanged at 100 yen per share.
Latest events from House Foods Group
- Sales and operating profit rose, but net profit fell due to last year's one-time gain.2810
Q1 202513 Jul 2026 - Sales and operating profit rose, but net profit fell on one-off factors; record profit targeted.2810
Q2 202513 Jul 2026 - Sales and operating profit increased, but net profit dropped sharply on one-time items.2810
Q4 202513 Jul 2026 - Sales and operating profit rose, but net profit fell on lower extraordinary gains; outlook unchanged.2810
Q3 202513 Jul 2026 - Profits fell on higher costs and weak demand, but stable dividends and a 2H recovery are forecast.2810
Q2 202613 Jul 2026 - Sales rose modestly, but profits fell sharply on higher costs; outlook and dividend unchanged.2810
Q1 202613 Jul 2026 - Sales grew modestly, but profits declined due to rising costs and inflationary pressures.2810
Q3 202613 Jul 2026 - Profits fell on higher costs and U.S. impairments, but FY2027 profit set to rebound on asset sales.2810
Q4 202613 Jul 2026